Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NutraMax Extends First Aid Line With Triple Antibiotic Bandages

This article was originally published in The Tan Sheet

Executive Summary

A new triple antibiotic adhesive bandage line will be launched by NutraMax by early spring. The four-SKU line, to be sold under the American White Cross First Aid Bandage brand, will be the first triple antibiotic bandage on the market, the company stated.

You may also be interested in...



FDA Solicitation Of Industry Input Prior To Draft Guidances Urged By PhRMA

FDA should seek counsel from drug manufacturers before issuing draft guidances, the Pharmaceutical Research & Manufacturers of America suggests in recent comments to the agency on the implementation of Good Guidance Practice provisions included in the FDA Modernization Act.

FDA Solicitation Of Industry Input Prior To Draft Guidances Urged By PhRMA

FDA should seek counsel from drug manufacturers before issuing draft guidances, the Pharmaceutical Research & Manufacturers of America suggests in recent comments to the agency on the implementation of Good Guidance Practice provisions included in the FDA Modernization Act.

FDA Solicitation Of Industry Input Prior To Draft Guidances Urged By PhRMA

FDA should seek counsel from drug manufacturers before issuing draft guidances, the Pharmaceutical Research & Manufacturers of America suggests in recent comments to the agency on the implementation of Good Guidance Practice provisions included in the FDA Modernization Act.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089133

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel